| ALERIE GUZMÁN DE LA FUENTE |
PID2021‑124465OA‑I00 |
Conditioning and memory of oligodendrocyte progenitor cells (OPCs): do OPCs remember inflammatory processes? |
Group 1 |
| ANA GUTIÉRREZ CASBAS |
PI21/01702 |
Chemokine and receptor expression profile in response to immunomodulatory treatment in tissue from patients with Crohn’s disease (TraffEC Study) |
Group 41 |
| ANA MARÍA PEIRÓ PEIRÓ |
ICI20/00146 |
Gender bias in pain medicine: from omics to healthcare |
Group 10 |
| ANA MARIA SANTOS RUIZ |
PID2019-110115GB-I00 |
The role of perinatal stress in temperament, psychopathology, and offspring reactivity (Childstress) |
Group 23 |
| ANTONIO MIGUEL PICÓ ALFONSO |
PI21/01012 |
Untangling the mechanisms of silencing and behaviour of silent corticotroph tumours. Clinical implications |
Group 20 |
| BERNAT SORIA ESCOMS |
ICI21/00016 |
Combined cell therapy for high‑risk COVID‑19 patients (DECODE‑19) |
Group 44 |
| CRISTINA ALENDA GONZÁLEZ |
DTS19/00178 |
Prognostic and molecular profile prediction of colorectal carcinomas using artificial intelligence technology applied to digitised tumour images |
Group 6 |
| ENRIQUE DE MADARIA PASCUAL |
PI22/00980 |
Lactated Ringer’s solution–based fluid therapy versus saline in acute pancreatitis: international multicentre randomized clinical trial, GALADRIEL study |
Group 25 |
| ENRIQUE DE MADARIA PASCUAL |
ICI20/00060 |
Ursodeoxycholic acid vs placebo for the prevention of recurrent biliary acute pancreatitis. Multicentre, randomized, double‑blind, placebo‑controlled clinical trial |
Group 25 |
| ENRIQUE DE MADARIA PASCUAL |
PI19/01628 |
Effect of aggressive versus non‑aggressive goal‑directed fluid therapy in the early phase of acute pancreatitis: multicentre randomized clinical trial, WATERFALL study |
Group 25 |
| ENRIQUE ROCHE COLLADO |
DTS21/00171 |
Development of a prototype for early mobilization in heart failure and its application in a real‑world setting: Mobilization in Heart Failure (HeFMob II) |
Group 36 |
| FRANCISCO JAVIER FERNÁNDEZ SÁNCHEZ |
PI22/01312 |
New grass allergens induced by urban pollution |
Group 11 |
| FRANCISCO JAVIER NARCISO ROMERO |
PID2020‑116998RB‑I00 |
Development of new MOFs |
Group 38 |
| FRANCISCO VERA GARCÍA |
RTI2018‑098893‑B‑I00 |
Assessment protocols and trunk exercise programmes to improve balance, functional capacity, and quality of life in older adults |
Group 1 |
| HUGO CABEDO MARTÍ |
PID2019-109762RB-I00 |
Phenotypic transitions of Schwann cells during myelin development, nerve regeneration, and hereditary demyelinating peripheral neuropathies (TranSchwann) |
Group 1 |
| JAVIER SÁEZ VALERO |
PI22/01329 |
Biomarkers revealing alterations in the apoE and APP pathways in Alzheimer’s disease, and their validation in cellular models (CHIVAT‑AD) |
Group 1 |
| JAVIER SÁEZ VALERO |
PI19/01359 |
Deciphering pathological interactions associated with Alzheimer’s disease between apolipoprotein E and the amyloid‑β precursor protein (APP) |
Group 1 |
| JESÚS VIOQUE LÓPEZ |
PI20/00557 |
PREDIMED+DM: Effect of weight loss through a hypocaloric Mediterranean diet and promotion of physical activity on the prevention of type 2 diabetes in individuals with metabolic syndrome |
Group 35 |
| JORGE MANZANARES ROBLES |
PI21/00488 |
Identification of cannabinoid biomarkers in alcohol dependence: translational research and new therapeutic strategies. Cannabial project. Animal studies |
Group 1 |
| JOSE LUIS CARBALLO CRESPO |
PID2019‑110400RB‑I00 |
Prevention of alcohol misuse in the educational context (PREVENALC) |
Group 15 |
| JOSE MANUEL GONZALEZ NAVAJAS |
PI22/01907 |
Multicytokine blockade strategy to reduce the development of hepatocellular carcinoma and improve immune checkpoint inhibitor therapy |
Grupo 4 |
| JOSE MANUEL GONZÁLEZ NAVAJAS |
PI19/01554 |
Effect of high salt intake on the development of hepatocellular carcinoma and on the immunological profile of patients with compensated cirrhosis |
Group 4 |
| JOSE SÁNCHEZ PAYÁ |
PI18/01685 |
Evaluation of the effectiveness of a programme to improve the appropriateness of surgical prophylaxis in surgery |
Group 2 |
| LUIS MIGUEL VALOR BECERRA |
PI19/00125 |
Cell‑specific biomarkers of peripheral fluids in trinucleotide disorders |
Group 1 |
| Mª ISABEL ORTS CORTES |
PI21/00738 |
Impact of hospitalization on nutritional status and the risk of dysphagia in people aged 65 years or older. Multicentre study “NUTRIFAG” |
Group 23 |
| MANUEL MOYA RAMÓN |
PID2019‑107721RB‑I00 |
Educating in new technologies throughout life with the aim of improving health through physical activity (SELFTRAINING) |
Group 36 |
| MARIA ELENA GARCÍA PAYA |
PI22/00827 |
Validation of prognostic biomarkers for Fabry disease |
Group 37 |
| MARIA EUGENIA GALIANA SÁNCHEZ |
HAR2017‑82366‑C2‑2‑P |
Past and present in the control of neglected poverty‑related diseases: the historical example of Mediterranean Europe and international health cooperation |
Group 23 |
| MARÍA VIRTUDES PÉREZ JOVER |
PID2021-125965OB-I00 |
Effectiveness study and mechanisms of change in the transdiagnostic psychological treatment for emotional disorders in primary care. A Stepped Wedge clinical trial |
Group 15 |
| MARIANO NICOLÁS ANDRÉS COLLADO |
PI21/00544 |
Synovial and systemic inflammation associated with silent urate crystal deposition in asymptomatic hyperuricemia |
Group 16 |
| NICOLÁS CUENCA NAVARRO |
PID2019‑106230RB‑I00 |
Retinitis pigmentosa and its association with shifts in the gut microbiome |
Group 27 |
| ROCÍO PÉREZ GONZÁLEZ |
P-100-FTPGB-2022 |
Identification of protein signatures in extracellular vesicles from a longitudinal cohort of individuals with a familial Alzheimer’s mutation: asymptomatic and symptomatic |
Group 1 |
| ROCÍO PÉREZ GONZÁLEZ |
AC22/00050 (JPND2022-115) |
Defining (sex and age) cell-specific epigenetic mechanisms underlying Environmental Enrichment/Exercise as non-pharmacological intervention for Alzheimer’s and Huntington’s disease and related potential noninvasive biomarkers |
Group 1 |
| RODRIGO JOVER MARTÍNEZ |
PI20/01527 |
Risk of colorectal cancer after resection of advanced polyps |
Group 6 |
| RUBÉN FRANCÉS GUARINOS |
PMP21/00082 |
Therapeutic targets and biomarkers from precision medicine in MAFLD (PreMed‑MAFLD) |
Group 41 |
| RUBÉN FRANCÉS GUARINOS |
PID2019‑107036RB‑I00 |
Role of LSECtin in restricting the transition from the innate immune response to the pathogenic adaptive CD4+ T‑cell response in cirrhosis |
Group 41 |
| SALVADOR MARTÍNEZ PÉREZ |
PIC18/00015 |
Intramuscular injection of autologous mononuclear cells in ALS patients. A phase II clinical trial |
Group 1 |
| VICENTE GIL GUILLÉN |
PI20/01304 |
Design and validation of a new gender‑perspective questionnaire to measure therapeutic adherence in chronic patients |
Group 20 |
